Surprisingly however, we have found that DIMand genistein downregulate CXCR4 and CXCL12 in both ER+ and ER− cell lines,indicating that these phytochemicals may be effective in the treatment of bothearly- and late-stage breast cancers. Here, CXCR4 is linked to breast carcinoma.